1187 related articles for article (PubMed ID: 26108573)
1. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
2. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis.
Saberi S; Stauffer JE; Jiang J; Garcia SD; Taylor AE; Schulte D; Ohkubo T; Schloffman CL; Maldonado M; Baughn M; Rodriguez MJ; Pizzo D; Cleveland D; Ravits J
Acta Neuropathol; 2018 Mar; 135(3):459-474. PubMed ID: 29196813
[TBL] [Abstract][Full Text] [Related]
3. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
[TBL] [Abstract][Full Text] [Related]
4. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.
Schludi MH; May S; Grässer FA; Rentzsch K; Kremmer E; Küpper C; Klopstock T; ; ; Arzberger T; Edbauer D
Acta Neuropathol; 2015 Oct; 130(4):537-55. PubMed ID: 26085200
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers.
Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M
Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446
[TBL] [Abstract][Full Text] [Related]
6. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases.
Porta S; Kwong LK; Trojanowski JQ; Lee VM
J Neuropathol Exp Neurol; 2015 Apr; 74(4):380-7. PubMed ID: 25756586
[TBL] [Abstract][Full Text] [Related]
7. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
[TBL] [Abstract][Full Text] [Related]
8. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD.
Khosravi B; Hartmann H; May S; Möhl C; Ederle H; Michaelsen M; Schludi MH; Dormann D; Edbauer D
Hum Mol Genet; 2017 Feb; 26(4):790-800. PubMed ID: 28040728
[TBL] [Abstract][Full Text] [Related]
10. C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity.
Lee YB; Baskaran P; Gomez-Deza J; Chen HJ; Nishimura AL; Smith BN; Troakes C; Adachi Y; Stepto A; Petrucelli L; Gallo JM; Hirth F; Rogelj B; Guthrie S; Shaw CE
Hum Mol Genet; 2017 Dec; 26(24):4765-4777. PubMed ID: 28973350
[TBL] [Abstract][Full Text] [Related]
11. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins.
Davidson Y; Robinson AC; Liu X; Wu D; Troakes C; Rollinson S; Masuda-Suzukake M; Suzuki G; Nonaka T; Shi J; Tian J; Hamdalla H; Ealing J; Richardson A; Jones M; Pickering-Brown S; Snowden JS; Hasegawa M; Mann DM
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):242-54. PubMed ID: 26538301
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review.
Schipper LJ; Raaphorst J; Aronica E; Baas F; de Haan R; de Visser M; Troost D
Neuropathol Appl Neurobiol; 2016 Oct; 42(6):547-60. PubMed ID: 26373655
[TBL] [Abstract][Full Text] [Related]
15. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.
May S; Hornburg D; Schludi MH; Arzberger T; Rentzsch K; Schwenk BM; Grässer FA; Mori K; Kremmer E; Banzhaf-Strathmann J; Mann M; Meissner F; Edbauer D
Acta Neuropathol; 2014 Oct; 128(4):485-503. PubMed ID: 25120191
[TBL] [Abstract][Full Text] [Related]
16. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
[TBL] [Abstract][Full Text] [Related]
17. NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility.
Gleixner AM; Verdone BM; Otte CG; Anderson EN; Ramesh N; Shapiro OR; Gale JR; Mauna JC; Mann JR; Copley KE; Daley EL; Ortega JA; Cicardi ME; Kiskinis E; Kofler J; Pandey UB; Trotti D; Donnelly CJ
Nat Commun; 2022 Jun; 13(1):3380. PubMed ID: 35697676
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar stress in C9orf72 and sporadic ALS spinal motor neurons precedes TDP-43 mislocalization.
Aladesuyi Arogundade O; Nguyen S; Leung R; Wainio D; Rodriguez M; Ravits J
Acta Neuropathol Commun; 2021 Feb; 9(1):26. PubMed ID: 33588953
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.
Baborie A; Griffiths TD; Jaros E; Perry R; McKeith IG; Burn DJ; Masuda-Suzukake M; Hasegawa M; Rollinson S; Pickering-Brown S; Robinson AC; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):601-12. PubMed ID: 25185840
[TBL] [Abstract][Full Text] [Related]
20. Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72.
McGurk L; Lee VM; Trojanowksi JQ; Van Deerlin VM; Lee EB; Bonini NM
J Neuropathol Exp Neurol; 2014 Sep; 73(9):837-45. PubMed ID: 25111021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
